Henry Meds Pricing Explained: Program Fees and Medication Cost

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we break down GLP-1 programs, weight-management protocols, and the genetic factors sitting behind every metabolic choice. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx holds no commercial relationship with Henry Meds or its parent company, and this page contains no affiliate links or paid placement.

Full head-to-head: PlexusDx vs Henry Meds →

Henry Meds is one of many telehealth brands operating in the GLP-1 and weight-management category. This review focuses narrowly on how Henry prices its program: the ladder of monthly rates, what each headline number actually represents, and what the subscription covers. It is fair-balance editorial context, not a purchase recommendation. Pricing verified July 20, 2026; program details as of April 2026.

How Henry Meds builds its pricing

Henry Meds runs on a telehealth-plus-pharmacy model: a licensed provider evaluates you virtually, and if you qualify, a prescription is routed either to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Because Henry prices per medication rather than charging a single flat membership, the number you pay depends entirely on which compound and which commitment length you choose.

The headline rate versus what you actually pay

The figure Henry advertises is its lowest possible rate, and it assumes you prepay a full year. The month-to-month price is meaningfully higher. Reading the ladder correctly means matching each number to its commitment term (figures verified July 20, 2026):

The flagship injectable

Compounded injectable semaglutide is Henry's lead product at $297 per month on a month-to-month basis. Prepaying lowers it: the six-month plan runs $1,482, or $247 per month, and the twelve-month plan runs $2,364, or $197 per month. That "$197/month" figure Henry markets is the twelve-month, paid-in-full rate, not what a new month-to-month subscriber pays.

Oral and alternative compounds

Sublingual semaglutide is $249 per month month-to-month, with a $179 per month tier available. Oral tirzepatide comes only as dissolving tablets, since Henry offers no injectable tirzepatide as of July 2026, sold as a three-month supply at $1,047, or $891 paid in full, with no published month-to-month rate. Injectable liraglutide is $179 per month and oral phentermine is $149 per month.

The fees Henry does not charge

There is no membership fee and no per-visit consultation charge. The provider evaluation is free, and nothing is billed until a prescription is actually written. Each subscription bundles the medication, dosing supplies, shipping, and ongoing clinical follow-up into the single monthly figure.

Commitment terms and the fine print

Henry does not publish a refund policy. Month-to-month and six-month plans auto-renew, and canceling a multi-month plan before it ends can require paying out the remaining balance unless a documented medical reason prevents you from continuing. Anyone weighing the lower prepaid rate against flexibility should read those terms closely and confirm current numbers on Henry Meds's official website before committing.

The one cost input Henry's pricing never covers

Every price on Henry's ladder buys the same thing: a compound and the service around it. What no telehealth price tag includes is the genetic terrain the compound acts on. Variants in FTO (fat-mass and obesity-associated), GLP1R (the GLP-1 receptor every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose handling) describe your baseline metabolic biology. These are pathway-level markers; they do not predict how you will respond to any specific drug, but they map the ground a clinician is prescribing into.

That is the layer PlexusDx adds. Before starting any protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2, so appetite-regulation and energy-balance context sits alongside the protocol itself. It is the test-before-you-invest approach that turns a pricing decision into an informed conversation with your provider.

How the PlexusDx approach compares

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. The difference is not a competing price sheet but the upstream genetic context most telehealth-only programs leave out.

Not affiliated: PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies referenced in this article.

Related reading on PlexusDx: GLP 1 What Is, GLP 1 Drugs, GLP 1 Receptor Agonist, GLP 1 Hormone.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review simply compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions About Henry Meds Pricing

Why is Henry's advertised price lower than what I would pay monthly?

The advertised rate is Henry's twelve-month, paid-in-full price. Its month-to-month rate for the flagship injectable compounded semaglutide is $297, while the marketed "$197/month" reflects prepaying a full year at $2,364. Always match a headline number to the commitment term attached to it before comparing.

Does Henry Meds charge a membership or consultation fee?

No. Henry charges no membership fee and no per-visit consultation fee, and the provider evaluation itself is free. Nothing is billed until a prescription is written, and each monthly subscription bundles medication, supplies, shipping, and ongoing follow-up into a single figure verified July 20, 2026.

What happens to my cost if I cancel a prepaid plan early?

Henry does not publish a refund policy. Month-to-month and six-month plans auto-renew, and ending a multi-month plan before it finishes can require paying out the remaining balance unless a documented medical reason prevents you from continuing. Confirm the current terms on Henry's official website first.

Does the Precision Peptide Genetic Test change what a program costs?

No. The test does not set or predict any program's price, nor does it predict drug response. It analyzes pathway-level variants such as FTO and MC4R, and TCF7L2 that shape baseline GLP-1 biology, context that applies no matter which telehealth service prescribes a compound.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.